These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38850339)

  • 1. Repression of resistance mechanisms of Pseudomonas aeruginosa: implications of the combination of antibiotics and phytoconstituents.
    Patra S; Biswas P; Karmakar S; Biswas K
    Arch Microbiol; 2024 Jun; 206(7):294. PubMed ID: 38850339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
    Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
    Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates.
    Kamer AMA; El Maghraby GM; Shafik MM; Al-Madboly LA
    BMC Microbiol; 2024 Jul; 24(1):277. PubMed ID: 39060955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of pomegranate and rosemary extracts in combination with antibiotics against antibiotic resistance and biofilm formation of Pseudomonas aeruginosa.
    Abu El-Wafa WM; Ahmed RH; Ramadan MA
    Braz J Microbiol; 2020 Sep; 51(3):1079-1092. PubMed ID: 32394240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genotypic detection of antibiotic resistance of
    Abbas HA; El-Ganiny AM; Kamel HA
    Afr Health Sci; 2018 Mar; 18(1):11-21. PubMed ID: 29977252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
    El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
    Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa.
    López-Pérez M; Haro-Moreno JM; Molina-Pardines C; Ventero MP; Rodríguez JC
    mSphere; 2021 Dec; 6(6):e0083621. PubMed ID: 34817240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
    Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
    Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
    Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic Resistance in Pseudomonas.
    Laborda P; Hernando-Amado S; Martínez JL; Sanz-García F
    Adv Exp Med Biol; 2022; 1386():117-143. PubMed ID: 36258071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.
    Lamers RP; Burrows LL
    Future Med Chem; 2016 Jun; 8(9):975-92. PubMed ID: 27228070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections.
    Santi I; Manfredi P; Maffei E; Egli A; Jenal U
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant
    de Melo Guedes GM; Pereira VC; Freitas AS; Honório de Souza PR; Chacon Parra AL; Brasil JA; de Medeiros Guedes RF; Pereira de Sousa PC; Aguiar Cordeiro R; Gadelha Rocha MF; Costa Sidrim JJ; Souza Collares Maia Castelo Branco D
    Future Microbiol; 2024; 19(6):495-508. PubMed ID: 38629920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.